|
NEXGEL, Inc. (NXGL) DCF Valuation
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
NEXGEL, Inc. (NXGL) Bundle
Discover NEXGEL, Inc.'s true value with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how changes influence NEXGEL, Inc. (NXGL) valuation – all within a convenient Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .7 | .7 | 1.6 | 2.0 | 4.1 | 6.4 | 10.0 | 15.7 | 24.5 | 38.3 |
| Revenue Growth, % | 0 | -6 | 130.12 | 32.04 | 99.66 | 56.43 | 56.43 | 56.43 | 56.43 | 56.43 |
| EBITDA | -1.9 | -2.2 | -2.2 | -3.1 | -2.7 | -6.0 | -9.3 | -14.6 | -22.9 | -35.8 |
| EBITDA, % | -258.86 | -327 | -141.78 | -151.81 | -66.76 | -93.35 | -93.35 | -93.35 | -93.35 | -93.35 |
| Depreciation | .1 | .1 | .1 | .3 | .4 | .6 | 1.0 | 1.6 | 2.4 | 3.8 |
| Depreciation, % | 9.34 | 7.42 | 7.29 | 14.7 | 10.83 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 |
| EBIT | -1.9 | -2.3 | -2.3 | -3.4 | -3.2 | -6.1 | -9.6 | -14.9 | -23.4 | -36.6 |
| EBIT, % | -268.2 | -334.42 | -149.07 | -166.5 | -77.6 | -95.52 | -95.52 | -95.52 | -95.52 | -95.52 |
| Total Cash | .3 | .0 | 13.4 | 6.6 | 2.7 | 3.9 | 6.1 | 9.6 | 15.0 | 23.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .1 | .2 | .2 | .6 | .8 | 1.3 | 2.0 | 3.2 | 5.0 |
| Account Receivables, % | 14.23 | 10.83 | 13.48 | 10.84 | 15.48 | 12.97 | 12.97 | 12.97 | 12.97 | 12.97 |
| Inventories | .1 | .2 | .3 | .5 | 1.3 | 1.6 | 2.5 | 3.9 | 6.2 | 9.6 |
| Inventories, % | 15.76 | 34.57 | 18.76 | 24.51 | 32.26 | 25.17 | 25.17 | 25.17 | 25.17 | 25.17 |
| Accounts Payable | .5 | .7 | .3 | .3 | 1.2 | 2.9 | 4.6 | 7.1 | 11.2 | 17.5 |
| Accounts Payable, % | 71.13 | 97.63 | 16.38 | 12.94 | 30.15 | 45.65 | 45.65 | 45.65 | 45.65 | 45.65 |
| Capital Expenditure | .0 | -.3 | -.3 | -.1 | -.7 | -1.1 | -1.7 | -2.7 | -4.2 | -6.5 |
| Capital Expenditure, % | 0 | -46.29 | -17.34 | -4.69 | -17.02 | -17.07 | -17.07 | -17.07 | -17.07 | -17.07 |
| Tax Rate, % | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 | 0.9724 |
| EBITAT | -1.9 | -2.3 | -3.4 | -4.4 | -3.1 | -6.1 | -9.5 | -14.9 | -23.3 | -36.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.6 | -2.5 | -4.1 | -4.4 | -3.7 | -5.4 | -10.0 | -15.6 | -24.4 | -38.2 |
| WACC, % | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 | 7.57 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -70.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -39 | |||||||||
| Terminal Value | -700 | |||||||||
| Present Terminal Value | -486 | |||||||||
| Enterprise Value | -557 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -557 | |||||||||
| Diluted Shares Outstanding, MM | 6 | |||||||||
| Equity Value Per Share | -98.15 |
What You Will Get
- Editable Forecast Inputs: Seamlessly adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: NEXGEL, Inc.’s (NXGL) financial data pre-loaded to streamline your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model that caters to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life NXGL Financials: Pre-filled historical and projected data for NEXGEL, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate NEXGEL’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize NEXGEL’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based NEXGEL, Inc. (NXGL) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates NEXGEL, Inc.'s (NXGL) intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation impacts.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis decisions.
Why Choose NEXGEL, Inc. (NXGL)?
- Innovative Solutions: Cutting-edge technology that enhances product performance and user experience.
- Proven Quality: High standards ensure reliable and effective products for all applications.
- Tailored Offerings: Customizable products to meet specific industry needs and customer requirements.
- User-Friendly Design: Intuitive interfaces and clear instructions facilitate easy adoption and use.
- Industry Recognition: Endorsed by professionals for excellence in innovation and service.
Who Should Use NEXGEL, Inc. (NXGL)?
- Healthcare Professionals: Understand the applications of hydrogel technology in patient care and treatment.
- Researchers: Explore innovative uses of NEXGEL's products in scientific studies and experiments.
- Investors: Evaluate market potential and performance metrics related to NEXGEL, Inc. (NXGL).
- Manufacturers: Integrate NEXGEL's advanced materials into your production processes for enhanced product offerings.
- Entrepreneurs: Discover business opportunities in the growing field of biocompatible materials and their applications.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled NEXGEL, Inc. (NXGL) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for NEXGEL, Inc. (NXGL).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.